R
Rare Thyroid Therapeutics
Profile managed by Bizz IdEgetis Therapeutics
Suecia
1-10 employees
Description
Swedish biopharmaceutical company focused on developing therapies for rare thyroid hormone disorders, including MCT8 deficiency (Allan-Herndon-Dudley Syndrome). Acquired by PledPharma and rebranded as Egetis Therapeutics.